Koyfin Home > Directory > Health Care > Intellia Thera CS > Cost of Goods Sold

Intellia Thera CS Cost of Goods Sold Chart (NTLA)

Intellia Thera CS annual/quarterly Cost of Goods Sold from 2014 to 2020.
  • Intellia Thera CS Cost of Goods Sold for the quarter ending September 09, 2020 was $40m a 20.19% increase of 8m year over year
  • Intellia Thera CS Cost of Goods Sold for the last 12 months ending September 09, 2020 was $144m a 24.67% increase of 35m year over year
  • Intellia Thera CS Annual Cost of Goods Sold for 2019 was $108m a 17.80% increase of 19m from 2018
  • Intellia Thera CS Annual Cost of Goods Sold for 2018 was $89m a 24.09% increase of 21m from 2017
  • Intellia Thera CS Annual Cost of Goods Sold for 2017 was $68m a 52.93% increase of 36m from 2016
Other Income Statement Metrics:
  • Intellia Thera CS EBITDA for the quarter ending December 12, 2018 was $-20m a -9.31% increase of 2m year over year
  • Intellia Thera CS Net Income for the quarter ending December 12, 2018 was $-19m a -12.01% increase of 2m year over year
  • Intellia Thera CS Total Revenue for the quarter ending September 09, 2018 was $7m a 9.99% increase of 1m year over year
View Chart On Koyfin

Quarterly NTLA Cost of Goods Sold Data

09/2020$40m
06/2020$38m
03/2020$35m
12/2019$32m
09/2019$28m
06/2019$25m
03/2019$24m
12/2018$20m
09/2018$23m
06/2018$23m

Annual NTLA Cost of Goods Sold Data

2019$108m
2018$89m
2017$68m
2016$32m
2015$11m
2014$2m